M&A Deal Summary |
|
|---|---|
| Date | 2009-11-01 |
| Target | ViiV Healthcare |
| Sector | Life Science |
| Buyer(s) |
GSK
Pfizer |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 35 |
| Sector: Life Science M&A | 14 of 28 |
| Type: Add-on Acquisition M&A Deals | 11 of 25 |
| Country: United Kingdom M&A | 3 of 5 |
| Year: 2009 M&A | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-05-12 |
Aspen Pharmacare
Durban, South Africa Aspen Pharmacare is a provider of specialty, branded, and generic pharmaceuticals, Aspen has an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. The Group continues to increase the number of lives benefitting from its products, reaching more than 150 countries. In line with the Group’s commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential. Aspen Pharmacare was founded in 1850 and is based in Durban, South Africa. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-18 |
NovaMin Technology
Alachua, Florida, United States NovaMin Technology, Inc. is an oral healthcare company focused on providing tooth remineralization technology products. The company develops over-the-counter and prescription products focused on reducing tooth sensitivity, reducing tooth decay, improving gum health and remineralizing teeth. Its proprietary material is made from the same bioactive material used in the most advanced bone regeneration material. |
Buy | $135M |
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 46 |
| Sector: Life Science M&A | 11 of 41 |
| Type: Add-on Acquisition M&A Deals | 10 of 33 |
| Country: United Kingdom M&A | 1 of 4 |
| Year: 2009 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-15 |
Wyeth
Collegeville, Pennsylvania, United States Wyeth is a research-driven pharmaceutical and health care products company. It discovers, develops, manufactures and markets pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. |
Buy | $68.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-12 |
Pfizer - Veterinary Products
Australia Virbac will acquire rights to a portfolio of livestock products historically marketed in Australia by Fort Dodge Animal Health for use in farm animals, primarily cattle and sheep. |
Sell | - |